The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,987
The first practical method for asymmetric epoxidation
Katsuki, T., & Sharpless, K. B. (1980) · Journal of the American Chemical Society · doi:10.1021/ja00538a077 · Cited by 2,635
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
Hetzel, D. J., Dent, J., Reed, W. D., Narielvala, F. M., Mackinnon, M., McCarthy, J. H., Mitchell, B., Beveridge, B. R., Laurence, B. H., Gibson, G. G., et al. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90162-x · Cited by 777
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase
Fellenius, E., Berglindh, T., Sachs, G., Olbe, L., Elander, B., Sjöstrand, S.-E., & Wallmark, B. (1981) · Nature · doi:10.1038/290159a0 · Cited by 619
Self-citationKlinkenberg-Knol, E. C., Nelis, F., Dent, J., Snel, P., Mitchell, B., Prichard, P., Lloyd, D., Havu, N., Frame, M. H., Romàn, J., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70135-1 · Cited by 534
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation
Larsson, H., Carlsson, E., Mattsson, H., Lundell, L., Sundler, F., Sundell, G., Wallmark, B., Watanabe, T., & Håkanson, R. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90938-8 · Cited by 511
Self-citationLind, T., Cederberg, C., Ekenved, G., Haglund, U., & Olbe, L. (1983) · Gut · doi:10.1136/gut.24.4.270 · Cited by 501
Self-citationEsomeprazole (40 Mg) Compared With Lansoprazole (30 Mg) in The Treatment of Erosive Esophagitis
Castell, D. O., Kahrilas, P. J., Richter, J. E., Vakil, N. B., Johnson, D., Zuckerman, S., Skammer, W., & Levine, J. G. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04094-1 · Cited by 436
Richter, J. E., Kahrilas, P. J., Johanson, J., Maton, P., Breiter, J. R., Hwang, C., Marino, V., Hamelin, B., Levine, J. G., & Esomeprazole Study Investigators* (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03600.x · Cited by 394
Walan, A., Bader, J.-P., Classen, M., Lamers, C. B. H. W., Piper, D. W., Rutgersson, K., & Eriksson, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901123200201 · Cited by 380
Cited by
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371
Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry
Khetan, S. K., & Collins, T. J. (2007) · Chemical Reviews · doi:10.1021/cr020441w · Cited by 1,145
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Tumour acidosis: from the passenger to the driver's seat
Corbet, C., & Feron, O. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.77 · Cited by 988
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Advances in covalent drug discovery
Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823
Micromotor-enabled active drug delivery for in vivo treatment of stomach infection
de Ávila, B. E.-F., Angsantikul, P., Li, J., Angel Lopez-Ramirez, M., Ramírez-Herrera, D. E., Thamphiwatana, S., Chen, C., Delezuk, J., Samakapiruk, R., Ramez, V., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00309-w · Cited by 638
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L. S., Stark, H., Thurmond, R. L., & Haas, H. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010249 · Cited by 575
Role of sulfur chirality in the chemical processes of biology
Bentley, R. (2005) · Chemical Society Reviews · doi:10.1039/b418284g · Cited by 540
Bauer, R. A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.005 · Cited by 534
Anti-quenching NIR-II molecular fluorophores for in vivo high-contrast imaging and pH sensing
Wang, S., Fan, Y., Li, D., Sun, C., Lei, Z., Lu, L., Wang, T., & Zhang, F. (2019) · Nature Communications · doi:10.1038/s41467-019-09043-x · Cited by 510
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds
Calcaterra, A., & D’Acquarica, I. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.07.008 · Cited by 481
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Gaba, M., & Mohan, C. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1495-5 · Cited by 366
Covalent inhibitors design and discovery.
De Cesco, S., Kurian, J., Dufresne, C., Mittermaier, A. K., & Moitessier, N. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.019 · Cited by 315
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Kinoshita, Y., Ishimura, N., & Ishihara, S. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18001 · Cited by 271
Krishnan, S., Miller, R. M., Tian, B., Mullins, R. D., Jacobson, M. P., & Taunton, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505194w · Cited by 260
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
McVicker, R. U., & O’Boyle, N. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02239 · Cited by 255
Macke, L., Schulz, C., Koletzko, L., & Malfertheiner, P. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15604 · Cited by 118
Acid Suppression Therapy: Where Do We Go from Here?
Scarpignato, C., Pelosini, I., & Di Mario, F. (2006) · Digestive Diseases · doi:10.1159/000091298 · Cited by 119
Designing Irreversible Inhibitors—Worth the Effort?
González‐Bello, C. (2016) · ChemMedChem · doi:10.1002/cmdc.201500469 · Cited by 74
Singh, G., Haileselassie, Y., Briscoe, L., Bai, L., Patel, A., Sanjines, E., Hendler, S., Singh, P. K., Garud, N. R., Limketkai, B. N., et al. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.11.005 · Cited by 30
A review on lactoferrin as a proton pump inhibitor
Santos-Pereira, C., Andrés, M. T., Fierro, J. F., Rodrigues, L. R., & Côrte-Real, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.075 · Cited by 13
Metadata
- Authors
- Olbe, L., Carlsson, E., & Lindberg, P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-02
- Volume
- 2
- Issue
- 2
- Pages
- 132-139
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2171444389
- Cited by
- 418
- References
- 32
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.